Sort   by:  
 Page size 
UnknownDiverse mechanisms associated with cyhalofop-butyl resistance in Chinese sprangletop (Leptochloa chinensis (L.) Nees): Characterization of target-site mutations and metabolic resistance-related genes in two resistant populations.
Not available
S-EPMC9742530 | biostudies-literature
UnknownABT-199 (venetoclax) and BCL-2 inhibitors in clinical development.
Not available
S-EPMC4654800 | biostudies-literature
UnknownAxon-like aligned conductive CNT/GelMA hydrogel fibers combined with electrical stimulation for spinal cord injury recovery.
Not available
S-EPMC10897856 | biostudies-literature
UnknownA genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity.
Not available
S-EPMC6475089 | biostudies-literature
UnknownCRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memory.
Not available
S-EPMC5800687 | biostudies-literature
UnknownRestriction of hepatitis B virus replication by c-Abl-induced proteasomal degradation of the viral polymerase.
Not available
S-EPMC6365112 | biostudies-literature
TranscriptomicsThe E3 ubiquitin ligase DDB1 controls homeostasis of hematopoietic stem and progenitor cells
Hematopoietic stem cells (HSC) are regulated to keep the balance between self-renewal and differentiation. However, little is known about post-translational regulations in HSCs. In this study, we characterize the role of DDB1, a component of the Cul4A-DDB1 E3 ubiquitin ligase complex, in HSCs and pr...
ORGANISM(S): Mus musculus 
2015-07-10 | E-GEOD-70658 | biostudies-arrayexpress
ProteomicsIntegrated DIA proteomics and lipidomics analysis on non-small cell lung cancer patients with TCM syndromes
Lung cancer remains the leading cause of mortality from malignant tumors, non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer cases, and individualized diagnosis and treatment in traditional Chinese Medicine (TCM) is an effective trend. In this study, a proteomics research wi...
ORGANISM(S): Homo Sapiens 
PXD024704 |
UnknownSafety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial.
Not available
S-EPMC11868595 | biostudies-literature
UnknownSintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.
Not available
S-EPMC10698618 | biostudies-literature
Sort   by:  
 Page size